Cantor Fitzgerald and LifeSci Capital acted as joint book running managers for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPRX:
- Eupraxia Raises US$55 Million to Accelerate EP-104GI and GI Pipeline
- Eupraxia Pharmaceuticals Plans Public Offering to Fund GI Drug Pipeline
- Eupraxia Pharmaceuticals announces common shares offering, no amount given
- Eupraxia Pharmaceuticals management to meet with Cantor
- Eupraxia Pharmaceuticals price target raised to $19 from $11 at Cantor Fitzgerald